"""
Disease Descriptions Module
Provides detailed descriptions for each skin condition class
"""

DISEASE_DESCRIPTIONS = {
    "Acne": {
        "description": "Acne is one of the most common skin conditions worldwide, affecting approximately 85% of people between ages 12-24, though it can persist well into adulthood. This chronic inflammatory disorder of the pilosebaceous unit (hair follicle and its associated oil gland) manifests in various forms ranging from mild comedones (blackheads and whiteheads) to severe cystic lesions. The condition primarily affects areas with the highest concentration of sebaceous glands, including the face, forehead, chest, upper back, and shoulders. Acne develops through a complex process involving four key factors: excessive sebum production, abnormal keratinization of follicular epithelium, colonization by Propionibacterium acnes bacteria, and inflammatory response. The severity can range from occasional breakouts to persistent, severe acne that may lead to permanent scarring and significant psychological distress. Modern understanding recognizes acne as a multifactorial disease influenced by genetics, hormones, lifestyle factors, and environmental triggers. While traditionally associated with adolescence, adult-onset acne is increasingly prevalent, particularly among women aged 25-40, often linked to hormonal imbalances, stress, and certain cosmetic products.",
        "root_cause": "The fundamental root cause of acne lies in the dysfunction of the pilosebaceous unit. At the cellular level, the process begins with hyperkeratinization—excessive production of keratin cells that line the hair follicle. These cells, instead of being shed normally, stick together and combine with sebum (oil) to form a plug that blocks the follicle opening. Simultaneously, hormonal influences, particularly androgens (male hormones present in both sexes), stimulate the sebaceous glands to produce excess sebum. This creates an oxygen-poor, lipid-rich environment ideal for the proliferation of Propionibacterium acnes, an anaerobic bacterium that normally lives harmlessly on skin. As these bacteria multiply, they produce inflammatory mediators and enzymes that break down sebum into free fatty acids, triggering an immune response. The body's inflammatory reaction causes the follicle wall to rupture, releasing bacteria, sebum, and cellular debris into the surrounding dermis, resulting in the characteristic red, swollen, painful lesions. Hormonal fluctuations during puberty, menstrual cycles, pregnancy, or due to conditions like polycystic ovary syndrome (PCOS) are primary triggers. Additionally, genetic predisposition plays a significant role—if both parents had acne, offspring have a 50% higher likelihood of developing severe acne.",
        "causes": "Excess sebum production, clogged hair follicles, bacterial infection (Propionibacterium acnes), hormonal changes, stress, and certain medications",
        "common_in": "Teenagers and young adults (85% affected), though adult acne is increasingly common, especially in women"
    },
    "Actinic Keratosis": {
        "description": "Actinic keratosis (AK), also known as solar keratosis, is a precancerous skin condition resulting from cumulative sun damage over many years. These rough, scaly patches typically develop on sun-exposed areas such as the face, ears, scalp, neck, hands, and forearms. The lesions may be flat or slightly raised, ranging in color from skin-toned to reddish-brown. While individual lesions are usually small (less than 2.5 cm), multiple patches often develop simultaneously. Actinic keratosis is medically significant because approximately 5-10% of untreated lesions can progress to squamous cell carcinoma, a type of skin cancer. The condition typically presents as rough, dry, or scaly patches that may be easier to feel than see. Colors can vary from flesh-toned to pink, red, or brown. Some lesions may itch, burn, or feel tender, though many are asymptomatic. The texture is often described as sandpaper-like or crusty. Multiple lesions commonly appear in sun-damaged areas, creating a field effect where the entire region shows signs of chronic UV damage. Early detection and treatment are essential for preventing malignant transformation. Treatment options include cryotherapy (freezing), topical medications, photodynamic therapy, chemical peels, and laser therapy. Prevention through sun protection is crucial, as the condition reflects decades of accumulated UV exposure. Regular dermatological examinations are recommended for individuals with multiple lesions or high-risk factors.",
        "root_cause": "The fundamental cause of actinic keratosis is chronic ultraviolet (UV) radiation exposure that causes cumulative DNA damage to keratinocytes, the predominant cells in the epidermis. Over years or decades, repeated UV exposure—primarily from sunlight but also from artificial sources like tanning beds—induces mutations in the p53 tumor suppressor gene and other critical genes that regulate cell growth and differentiation. This DNA damage accumulates faster than the body's repair mechanisms can correct it, particularly in individuals with fair skin who have less protective melanin. The damaged keratinocytes begin to proliferate abnormally, forming dysplastic (precancerous) lesions. UV radiation, particularly UVB rays, directly damages DNA by creating thymine dimers and other photoproducts that distort the DNA structure. UVA rays contribute by generating reactive oxygen species that cause oxidative damage. The immune system's ability to detect and eliminate these abnormal cells diminishes with age and chronic sun exposure, allowing the lesions to persist and potentially progress. Geographic location, occupational sun exposure (outdoor workers), recreational activities, and historical sunburns all contribute to cumulative UV dose. The latency period between exposure and lesion development can span decades, which is why AK typically appears in middle-aged and older adults despite originating from sun exposure in youth.",
        "causes": "Cumulative ultraviolet (UV) radiation exposure from sunlight or tanning beds, which damages skin cell DNA over time",
        "common_in": "Adults over 40 with fair skin, light-colored eyes, history of frequent sun exposure or sunburns, and those living in sunny climates"
    },
    "Benign Tumors": {
        "description": "Benign skin tumors are non-cancerous growths that arise from various cell types within the skin. Unlike malignant tumors, they do not invade surrounding tissues or spread to other parts of the body (metastasize). Common types include lipomas (fatty tissue growths), dermatofibromas (fibrous tissue nodules), sebaceous cysts (oil gland blockages), neurofibromas (nerve tissue growths), skin tags (acrochordons), cherry angiomas (vascular growths), and keratoacanthomas (rapidly growing dome-shaped lesions). These tumors typically grow slowly and may remain stable for years, though some types like keratoacanthomas can grow rapidly before spontaneously regressing. Lipomas are soft, movable lumps of fat cells beneath the skin, most common on the trunk, neck, and extremities. Dermatofibromas are firm, brownish nodules often found on the legs, typically arising after minor trauma like insect bites. Sebaceous cysts are smooth, round lumps filled with keratin that can become inflamed or infected. While generally harmless, benign tumors can cause cosmetic concerns or physical discomfort depending on their size and location. Some may require removal if they become painful, infected, interfere with daily activities, or cause psychological distress. Diagnosis is usually clinical, though biopsy may be performed if malignancy cannot be excluded. Treatment options include surgical excision, cryotherapy, laser therapy, or simple observation. Regular monitoring ensures any changes are detected early, as some benign lesions can rarely undergo malignant transformation.",
        "root_cause": "Benign skin tumors arise from localized abnormal proliferation of specific cell types within the skin, triggered by various mechanisms depending on the tumor type. Lipomas develop when adipocytes (fat cells) multiply excessively in the subcutaneous tissue, often linked to genetic factors—familial multiple lipomatosis runs in families with autosomal dominant inheritance. The exact trigger for this localized fat cell proliferation remains unclear, though chromosomal abnormalities involving the HMGA2 gene have been identified in some cases. Dermatofibromas result from a reactive proliferation of fibroblasts and histiocytes, typically following minor trauma, insect bites, or inflammation. The body's wound healing response becomes dysregulated, leading to excessive collagen deposition and fibrous tissue formation that persists rather than resolving. Sebaceous cysts (epidermoid or pilar cysts) form when the opening of a hair follicle or sebaceous gland becomes blocked, causing keratin and sebum to accumulate in a sac-like structure beneath the skin. This blockage can result from trauma, inflammation, or developmental abnormalities. Neurofibromas arise from Schwann cells surrounding peripheral nerves, often associated with genetic conditions like neurofibromatosis type 1 (NF1), caused by mutations in the NF1 tumor suppressor gene. Skin tags develop in areas of friction and are associated with obesity, diabetes, and hormonal changes during pregnancy. The common thread among benign tumors is localized, controlled cell proliferation without the invasive or metastatic properties of cancer, though the specific cellular and molecular mechanisms vary by tumor type.",
        "causes": "Various factors including genetic predisposition, hormonal influences, skin trauma, chronic irritation, and sun exposure depending on tumor type",
        "common_in": "Adults of all ages; specific types have different age distributions (lipomas common in 40-60 age group)"
    },
    "Bullous": {
        "description": "Bullous diseases encompass a group of skin disorders characterized by the formation of bullae—large, fluid-filled blisters greater than 5mm in diameter. These conditions can be autoimmune (like bullous pemphigoid and pemphigus vulgaris), inherited (epidermolysis bullosa), or acquired through infections, medications, or physical trauma. In autoimmune bullous diseases, the body's immune system mistakenly attacks proteins that hold skin layers together, causing separation and blister formation. Blisters may appear on the skin, mucous membranes, or both. The condition can range from mild localized involvement to severe widespread disease affecting quality of life. Bullous pemphigoid, the most common autoimmune blistering disease, typically affects elderly individuals with tense blisters on flexural areas, often preceded by itchy, urticarial plaques. Pemphigus vulgaris produces flaccid blisters that easily rupture, leaving painful erosions, frequently involving oral mucosa before skin. Dermatitis herpetiformis, associated with celiac disease, presents with intensely itchy, grouped vesicles on elbows, knees, and buttocks. Epidermolysis bullosa, a group of inherited disorders, causes skin fragility from birth, with blistering from minimal trauma. Proper diagnosis through skin biopsy and immunofluorescence testing is crucial for appropriate treatment. Management typically involves immunosuppressive medications for autoimmune forms, wound care, infection prevention, and addressing underlying causes when identifiable.",
        "root_cause": "The root cause varies by bullous disease type. In autoimmune bullous diseases like pemphigus and pemphigoid, the fundamental problem is a breakdown in immune tolerance, where the immune system produces autoantibodies against structural proteins that maintain skin integrity. In pemphigus vulgaris, IgG autoantibodies target desmoglein 3 and desmoglein 1, proteins in desmosomes that hold keratinocytes together. When these antibodies bind to desmogleins, they disrupt cell-to-cell adhesion, causing acantholysis (separation of epidermal cells) and intraepidermal blister formation. In bullous pemphigoid, IgG autoantibodies target BP180 and BP230, components of hemidesmosomes that anchor the epidermis to the dermis. Antibody binding activates complement and recruits inflammatory cells, leading to basement membrane zone destruction and subepidermal blister formation. The trigger for autoantibody production remains unclear but may involve genetic susceptibility (HLA associations), environmental factors, medications, or infections that cause molecular mimicry. In inherited forms like epidermolysis bullosa, genetic mutations affect genes encoding structural proteins such as collagen VII, keratin 5/14, or laminin 332, resulting in fragile skin that blisters with minimal mechanical stress. Drug-induced bullous reactions occur when medications trigger immune responses or directly damage skin structures. Infectious causes like bullous impetigo result from bacterial toxins that cleave desmoglein 1.",
        "causes": "Autoimmune reactions targeting skin adhesion proteins, genetic mutations, infections (herpes, impetigo), medications, burns, or friction injuries",
        "common_in": "Varies by type; bullous pemphigoid typically affects elderly (over 60), while pemphigus can occur at any adult age"
    },
    "Candidiasis": {
        "description": "Cutaneous candidiasis is a fungal infection caused by Candida species, most commonly Candida albicans. This yeast naturally exists on human skin and mucous membranes but can overgrow under certain conditions, leading to infection. Skin candidiasis typically develops in warm, moist areas such as skin folds (under breasts, groin, armpits), between fingers and toes, and around nails. The infection presents as bright red, itchy rashes with satellite pustules at the edges—a characteristic feature. The affected skin may appear macerated (softened and whitened) with well-defined borders. Risk factors include obesity, diabetes, antibiotic use, immunosuppression, and excessive sweating. Candida thrives in warm, moist environments where skin surfaces touch, creating ideal conditions for proliferation. Intertrigo, candidal infection of skin folds, causes red, raw-appearing skin with burning and itching. Candidal paronychia affects the nail folds, causing redness, swelling, and pain around nails. Diaper dermatitis in infants often involves secondary candidal infection. Oral thrush and vaginal yeast infections are mucosal forms of candidiasis. Chronic mucocutaneous candidiasis, a rare condition, involves persistent or recurrent infections due to immune defects. Treatment involves antifungal medications (topical or oral depending on severity) and addressing underlying conditions. Prevention focuses on keeping skin dry, managing diabetes, avoiding unnecessary antibiotics, and maintaining good hygiene.",
        "root_cause": "The root cause of cutaneous candidiasis is the opportunistic overgrowth of Candida yeast, which normally exists as a commensal organism on skin and mucous membranes in small numbers, kept in check by the body's immune system and competing bacterial flora. When this balance is disrupted, Candida proliferates uncontrollably and transitions from a harmless commensal to a pathogenic state. Several factors trigger this transformation. Antibiotic use disrupts the normal bacterial microbiome that competes with Candida for nutrients and space, allowing yeast overgrowth. Diabetes mellitus creates a glucose-rich environment in tissues and impairs immune function, particularly neutrophil activity, facilitating fungal growth. Immunosuppression from HIV/AIDS, chemotherapy, corticosteroids, or immunosuppressive medications weakens the body's ability to control Candida populations. Obesity creates deep skin folds that trap moisture and heat, providing ideal conditions for yeast proliferation. Occlusive clothing, diapers, or bandages similarly create warm, moist environments. Hormonal changes during pregnancy alter vaginal pH and immune responses, increasing susceptibility. Candida's virulence factors include the ability to form biofilms, produce hydrolytic enzymes (proteases, phospholipases) that damage host tissues, and switch between yeast and hyphal forms—the hyphal form being more invasive. The organism adheres to epithelial cells via adhesins, penetrates superficial skin layers, and triggers inflammatory responses that cause the characteristic redness, itching, and discomfort.",
        "causes": "Overgrowth of Candida yeast due to moisture, warmth, antibiotic use disrupting normal flora, diabetes, weakened immunity, or hormonal changes",
        "common_in": "People with diabetes, obesity, weakened immune systems, those taking antibiotics or corticosteroids, and infants (diaper rash)"
    },
    "Drug Eruption": {
        "description": "Drug eruptions are adverse skin reactions triggered by medications, representing one of the most common types of adverse drug reactions. These reactions can manifest in numerous ways, from mild maculopapular rashes (flat and raised red spots) to severe, life-threatening conditions like Stevens-Johnson syndrome or toxic epidermal necrolysis. Symptoms typically appear within days to weeks of starting a new medication but can occur with drugs taken for extended periods. Common culprits include antibiotics (especially penicillins and sulfonamides), NSAIDs, anticonvulsants, and allopurinol. The reaction may include itching, redness, blistering, fever, and in severe cases, mucosal involvement. Identifying and discontinuing the offending drug is essential for recovery. Maculopapular eruptions, the most common type, present as widespread red macules and papules resembling viral exanthems. Urticarial reactions cause hives and angioedema. Fixed drug eruptions produce round, dusky red patches that recur in the same location with drug re-exposure. Photosensitivity reactions occur when medication makes skin more sensitive to sunlight. Severe cutaneous adverse reactions (SCARs) including Stevens-Johnson syndrome, toxic epidermal necrolysis, and DRESS syndrome (Drug Reaction with Eosinophilia and Systemic Symptoms) are medical emergencies requiring immediate hospitalization. Diagnosis involves careful medication history, timing of symptom onset, and sometimes patch testing or drug provocation tests. Treatment includes drug discontinuation, supportive care, antihistamines, topical or systemic corticosteroids, and intensive care for severe reactions.",
        "root_cause": "Drug eruptions arise from complex immune-mediated or non-immune reactions to medications or their metabolites. In immune-mediated reactions, the drug or its metabolite acts as a hapten, binding to proteins to form immunogenic complexes that trigger immune responses. Type I hypersensitivity reactions involve IgE antibodies causing immediate urticaria or anaphylaxis. Type IV delayed hypersensitivity reactions, mediated by T-cells, cause most drug eruptions including maculopapular rashes and severe reactions like Stevens-Johnson syndrome. The hapten hypothesis suggests small drug molecules bind to self-proteins, creating neoantigens recognized as foreign by the immune system. The pharmacological interaction (p-i) concept proposes that some drugs directly interact with immune receptors without prior protein binding, activating T-cells. Genetic factors play crucial roles—specific HLA alleles dramatically increase risk for certain drug reactions (HLA-B*5701 with abacavir, HLA-B*1502 with carbamazepine in Asian populations, HLA-B*5801 with allopurinol). These genetic variants affect how drugs are presented to T-cells, determining susceptibility. Metabolic factors also contribute—slow acetylators have higher risk for sulfonamide reactions due to accumulation of toxic metabolites. Viral infections, particularly HIV and herpes viruses, increase drug eruption risk through immune system alterations. Non-immune mechanisms include direct toxic effects, cumulative drug effects, drug interactions, and overdose. The severity and type of reaction depend on the specific drug, dose, duration, individual genetic makeup, immune status, and concurrent conditions.",
        "causes": "Immune-mediated or non-immune reactions to medications including antibiotics, anticonvulsants, NSAIDs, chemotherapy drugs, and contrast dyes",
        "common_in": "Anyone taking medications; higher risk in those on multiple drugs, with HIV/AIDS, or with previous drug reactions"
    },
    "Eczema": {
        "description": "Eczema, medically known as atopic dermatitis, is a chronic inflammatory skin condition characterized by intensely itchy, dry, and inflamed skin. It's part of the 'atopic triad' along with asthma and allergic rhinitis, suggesting a genetic predisposition to allergic conditions. Eczema typically appears in patches that may be red, scaly, cracked, or weeping. In infants, it often affects the face and scalp, while in older children and adults, it commonly appears in skin creases (elbows, knees, neck). The condition follows a relapsing-remitting course with flare-ups triggered by various factors. Chronic scratching can lead to thickened, leathery skin (lichenification). The intense itching significantly impacts quality of life, disrupting sleep and daily activities. Eczema often begins in early childhood—60% of cases develop before age 1, and 90% before age 5—though adult-onset eczema is increasingly recognized. The severity ranges from mild dryness and occasional itching to severe, widespread inflammation with oozing and crusting. Secondary bacterial infections, particularly with Staphylococcus aureus, commonly complicate eczema. Eczema herpeticum, a serious complication from herpes simplex virus infection, requires immediate medical attention. Management focuses on moisturizing to repair the skin barrier, avoiding triggers, controlling inflammation with topical corticosteroids or calcineurin inhibitors, and managing itch. Newer treatments include biologics targeting specific immune pathways and JAK inhibitors for severe cases.",
        "root_cause": "The root cause of eczema involves a complex interplay of genetic factors, immune dysfunction, and skin barrier defects. At the cellular level, mutations in the filaggrin gene (FLG) are found in approximately 30% of eczema patients. Filaggrin is a crucial protein that aggregates keratin filaments in the stratum corneum, maintaining skin barrier integrity. Loss of functional filaggrin leads to increased transepidermal water loss, dry skin, and enhanced penetration of allergens, irritants, and microbes. This barrier dysfunction triggers immune activation. The immune component involves a skewed T-helper cell response, with Th2 cells predominating in acute lesions, producing cytokines like IL-4, IL-5, and IL-13 that promote IgE production, eosinophil recruitment, and inhibit antimicrobial peptide production. Chronic lesions show a shift toward Th1 and Th22 responses. This immune dysregulation causes inflammation, itching, and further barrier damage, creating a vicious cycle. The skin microbiome is altered in eczema, with Staphylococcus aureus colonization in 90% of lesional skin compared to 5% in healthy individuals. S. aureus produces toxins that act as superantigens, amplifying inflammation. Environmental triggers including allergens (dust mites, pollen, pet dander), irritants (soaps, detergents, fragrances), climate changes, stress, and infections exacerbate the condition by further compromising the barrier and activating immune responses. The genetic predisposition combined with environmental exposures determines disease expression and severity.",
        "causes": "Complex interplay of genetic factors (filaggrin gene mutations), immune dysfunction, skin barrier defects, and environmental triggers (allergens, irritants, stress)",
        "common_in": "Children (10-20% affected), often starting in infancy; 60% develop symptoms before age 1, though it can persist or begin in adulthood"
    },
    "Infestations/Bites": {
        "description": "Skin infestations and arthropod bites encompass conditions caused by parasites, insects, and arachnids. Scabies, caused by the Sarcoptes scabiei mite, creates intensely itchy burrows in the skin, particularly between fingers, wrists, and genital areas. Pediculosis (lice infestation) affects the scalp, body, or pubic area. Bed bug bites appear as grouped, itchy red welts, often in a linear pattern. Flea bites typically cluster around ankles and legs. Spider bites can range from minor irritation to serious reactions requiring medical attention. These conditions cause significant discomfort through itching, inflammation, and secondary infections from scratching. Scabies presents with severe nocturnal itching and characteristic burrows—thin, wavy lines on skin where mites tunnel. The immune response to mite proteins causes widespread itching beyond burrow sites. Crusted (Norwegian) scabies, occurring in immunocompromised individuals, involves thousands of mites and thick, crusted skin. Head lice cause scalp itching and visible nits (eggs) attached to hair shafts. Body lice live in clothing seams and feed on skin, associated with poor hygiene. Pubic lice (crabs) infest coarse body hair. Bed bugs hide in mattresses and furniture, feeding at night, leaving grouped bites often in rows. Proper identification is crucial for appropriate treatment and preventing spread to others. Treatment varies by condition—scabies requires permethrin cream or oral ivermectin, lice need pediculicides and nit removal, bed bugs require environmental control and pest management.",
        "root_cause": "The root cause varies by the specific parasite or arthropod involved. Scabies results from infestation by the Sarcoptes scabiei mite, an obligate human parasite that cannot survive off the host for more than 2-3 days. Female mites burrow into the stratum corneum, laying eggs and depositing fecal matter. The intense itching is an allergic reaction to mite proteins, saliva, eggs, and feces, typically developing 2-6 weeks after initial infestation as the immune system becomes sensitized. Transmission occurs through prolonged skin-to-skin contact, making household members and sexual partners at high risk. Lice infestations result from direct contact with infested individuals or sharing personal items like combs, hats, or bedding. Head lice (Pediculus humanus capitis) have adapted to grasp hair shafts and feed on blood several times daily. Their saliva contains anticoagulants and immunogenic proteins that cause itching and inflammation. Bed bug infestations (Cimex lectularius) occur when these nocturnal insects establish populations in sleeping areas. They're attracted by carbon dioxide and body heat, feeding for 5-10 minutes before retreating. Their saliva contains anesthetic and anticoagulant compounds; the itchy welts result from immune reactions to these proteins. Flea bites occur when cat or dog fleas (Ctenocephalides species) feed on humans, usually when preferred hosts are unavailable. Spider bites are typically defensive reactions when spiders are accidentally disturbed. Most spider bites cause only local reactions, but species like brown recluse and black widow can cause serious systemic effects through venom containing neurotoxins or cytotoxic enzymes.",
        "causes": "Direct contact with parasites (mites, lice), insect bites (mosquitoes, fleas, bed bugs, spiders), or exposure to infested environments or individuals",
        "common_in": "Anyone can be affected; scabies spreads in close-contact settings; bed bugs in travelers; lice common in school-age children"
    },
    "Lichen": {
        "description": "Lichen planus is an inflammatory condition affecting the skin, mucous membranes, hair, and nails. On the skin, it presents as distinctive purplish, flat-topped, polygonal papules with fine white lines on the surface called Wickham's striae. These lesions are often intensely itchy and commonly appear on the wrists, ankles, lower back, and genital areas. Oral lichen planus affects the mouth lining, causing white, lacy patterns or painful erosions. The condition can also cause nail changes and scalp involvement leading to scarring hair loss. While the exact cause remains unknown, it's believed to be an immune-mediated reaction. Most cases resolve within 1-2 years, though oral and nail involvement may persist longer. The name lichen refers to the resemblance of skin lesions to lichen growing on rocks. Cutaneous lichen planus typically presents with the 6 Ps: purple, polygonal, planar (flat-topped), pruritic (itchy), papules, and plaques. The Koebner phenomenon—lesions appearing at sites of trauma—is common. Oral lichen planus affects 1-2% of the population, presenting as white, lacy reticular patterns, erosive lesions, or atrophic areas. Erosive oral lichen planus can be painful, affecting eating and speaking. Lichen planopilaris causes scarring alopecia on the scalp. Nail involvement produces longitudinal ridging, thinning, or complete nail loss. Treatment includes topical or systemic corticosteroids, retinoids, immunosuppressants, and phototherapy for extensive disease. Oral lesions require regular monitoring as they carry a small risk of malignant transformation.",
        "root_cause": "The root cause of lichen planus is a T-cell mediated autoimmune response targeting basal keratinocytes in the epidermis. Cytotoxic CD8+ T-lymphocytes infiltrate the dermoepidermal junction and attack basal keratinocytes, causing apoptosis (programmed cell death) and lichenoid tissue reaction. The trigger for this immune attack remains unclear, but several mechanisms are proposed. Molecular mimicry suggests that viral or bacterial antigens share structural similarities with keratinocyte proteins, causing the immune system to mistakenly attack self-tissues. Hepatitis C virus infection is strongly associated with lichen planus, particularly in certain geographic regions, supporting this theory. Drug-induced lichenoid reactions occur with medications including antimalarials, beta-blockers, NSAIDs, and ACE inhibitors, suggesting drugs may alter keratinocyte antigens or directly activate T-cells. Contact allergens in dental materials (amalgam, gold) can trigger oral lichen planus through delayed hypersensitivity reactions. Genetic factors play a role, with certain HLA types (HLA-DR1, HLA-DR10) more common in affected individuals. Stress and emotional factors may trigger or exacerbate disease through neuroimmune pathways. At the molecular level, activated T-cells release cytokines (TNF-alpha, IFN-gamma) and cytotoxic mediators (perforin, granzyme B) that induce keratinocyte apoptosis. Langerhans cells present altered keratinocyte antigens to T-cells, perpetuating the immune response. The characteristic Wickham's striae result from focal thickening of the granular cell layer. The purple color comes from melanin incontinence—melanin released from dying basal keratinocytes is phagocytosed by dermal macrophages.",
        "causes": "Immune system dysfunction (T-cell mediated); may be triggered by hepatitis C infection, certain medications, dental materials, or stress",
        "common_in": "Adults aged 30-60 years; slightly more common in women; oral lichen planus affects about 1-2% of the population"
    },
    "Lupus": {
        "description": "Cutaneous lupus erythematosus refers to skin manifestations of lupus, an autoimmune disease where the immune system attacks healthy tissue. The most recognizable form is the butterfly (malar) rash—a red, flat or raised rash across the cheeks and nose bridge, sparing the nasolabial folds. Discoid lupus causes coin-shaped, scaly plaques that can lead to scarring and pigment changes. Subacute cutaneous lupus produces ring-shaped or scaly patches on sun-exposed areas. Photosensitivity is a hallmark feature, with sun exposure triggering or worsening skin lesions. Cutaneous lupus may occur alone or as part of systemic lupus erythematosus (SLE), which affects multiple organs. Early diagnosis and sun protection are essential for management. Cutaneous lupus encompasses three main subtypes: acute cutaneous lupus (including the malar rash), subacute cutaneous lupus erythematosus (SCLE), and chronic cutaneous lupus (primarily discoid lupus). Acute cutaneous lupus often indicates active systemic disease. SCLE presents as photosensitive, non-scarring lesions in sun-exposed areas, associated with anti-Ro/SSA antibodies. Discoid lupus causes disfiguring scarring, hair loss, and pigmentary changes, but only 5-10% of patients develop systemic disease. Other manifestations include lupus panniculitis (inflammation of subcutaneous fat), chilblain lupus (painful lesions on fingers and toes), and lupus tumidus (smooth, indurated plaques). Treatment includes sun protection, topical corticosteroids, antimalarial drugs (hydroxychloroquine), immunosuppressants, and biologics for severe cases. Regular monitoring for systemic involvement is crucial.",
        "root_cause": "The root cause of cutaneous lupus involves a complex breakdown in immune tolerance, leading to autoantibody production and immune complex deposition in skin. The pathogenesis involves genetic susceptibility, environmental triggers, and immune dysregulation. Genetic factors include polymorphisms in genes regulating immune responses, complement proteins, and apoptosis. Over 100 genetic loci are associated with lupus susceptibility. Environmental triggers, particularly ultraviolet (UV) radiation, play a crucial role in cutaneous lupus. UV light induces keratinocyte apoptosis, causing translocation of nuclear antigens (DNA, Ro, La) to the cell surface where they become accessible to autoantibodies. UV also stimulates production of type I interferons, key cytokines in lupus pathogenesis. The immune system in lupus patients shows defective clearance of apoptotic cells, leading to accumulation of nuclear material that stimulates autoantibody production. B-cells produce autoantibodies against nuclear antigens (anti-dsDNA, anti-Sm, anti-Ro/SSA, anti-La/SSB). These autoantibodies form immune complexes that deposit in the dermoepidermal junction, activating complement and recruiting inflammatory cells. Complement activation products damage keratinocytes and blood vessels. Type I interferons, produced by plasmacytoid dendritic cells in response to immune complexes, amplify inflammation and autoantibody production. T-cells show abnormal activation and cytokine production. Hormonal factors, particularly estrogen, influence disease expression, explaining the female predominance. Medications (hydralazine, procainamide, anti-TNF agents) can induce drug-induced lupus through mechanisms including altered DNA methylation and increased apoptosis.",
        "causes": "Autoimmune dysfunction where the immune system produces antibodies against the body's own tissues; genetic predisposition and environmental triggers (UV light, infections)",
        "common_in": "Women of childbearing age (15-44 years); 9 times more common in women; higher prevalence in African American, Hispanic, and Asian populations"
    },
    "Moles": {
        "description": "Moles, medically termed melanocytic nevi, are common benign skin growths composed of clusters of melanocytes (pigment-producing cells). They appear as small, usually brown spots and can be flat or raised, round or oval, with smooth or rough surfaces. Most people develop 10-40 moles by adulthood, with new moles appearing through young adulthood. Moles can be present at birth (congenital nevi) or develop later (acquired nevi). While the vast majority are harmless, monitoring moles for changes is important because melanoma, a serious skin cancer, can develop within existing moles or appear as new abnormal growths. The ABCDE rule helps identify suspicious changes: Asymmetry, Border irregularity, Color variation, Diameter over 6mm, and Evolution over time. Moles develop when melanocytes grow in clusters rather than spreading throughout the skin. Congenital melanocytic nevi are present at birth, occurring in 1-2% of newborns. Small congenital nevi (less than 1.5 cm) carry minimal melanoma risk, while giant congenital nevi (over 20 cm) have increased risk and may require prophylactic removal. Acquired nevi typically appear in childhood and adolescence, peaking in the 20s-30s, then gradually fading with age. Common acquired nevi are uniform in color and symmetrical. Atypical (dysplastic) nevi are larger, irregularly shaped, and variably pigmented, serving as markers for increased melanoma risk. Multiple atypical nevi, especially with family history of melanoma, constitute dysplastic nevus syndrome. Regular self-examination and professional skin checks are essential for early melanoma detection. Most moles require no treatment unless they show concerning changes, cause symptoms, or for cosmetic reasons.",
        "root_cause": "The root cause of mole formation involves localized proliferation of melanocytes, the pigment-producing cells normally distributed individually along the dermoepidermal junction. During embryonic development and childhood, melanocytes migrate from the neural crest to the skin. Moles form when melanocytes cluster together rather than remaining evenly spaced. The exact trigger for this clustering is not fully understood but involves genetic and environmental factors. Genetic factors play a significant role—mole number and type are heritable traits. Specific genes regulate melanocyte proliferation and differentiation, including BRAF, NRAS, and genes controlling the MAPK signaling pathway. Activating mutations in BRAF (particularly BRAF V600E) are found in most acquired nevi, causing increased melanocyte proliferation. However, these mutations alone are insufficient for melanoma development; additional genetic changes are required for malignant transformation. This explains why most moles remain benign despite harboring oncogenic mutations—they enter a state of oncogene-induced senescence, a protective mechanism preventing uncontrolled growth. Environmental factors, particularly ultraviolet radiation exposure, influence mole development. Sun exposure in childhood increases mole number, especially in fair-skinned individuals. UV radiation causes DNA damage and mutations in melanocytes, promoting nevus formation. Hormonal factors also play a role—moles often appear or darken during puberty and pregnancy due to hormonal influences on melanocyte activity. Congenital nevi result from errors in melanocyte migration and proliferation during fetal development. The size of congenital nevi correlates with the timing of the developmental error—earlier errors produce larger nevi. Atypical nevi show architectural disorder and cytologic atypia, representing an intermediate state between normal nevi and melanoma.",
        "causes": "Clusters of melanocytes forming during development; influenced by genetics, sun exposure, and hormonal changes (pregnancy, puberty)",
        "common_in": "Everyone; fair-skinned individuals tend to have more moles; number peaks in young adulthood and decreases with age"
    },
    "Psoriasis": {
        "description": "Psoriasis is a chronic autoimmune condition causing rapid skin cell turnover—cells that normally take a month to mature do so in just days. This accelerated growth leads to thick, silvery-white scales overlying red, inflamed patches called plaques. The most common form, plaque psoriasis, typically affects the scalp, elbows, knees, and lower back, but can appear anywhere. Other forms include guttate (small, drop-shaped lesions), inverse (smooth patches in skin folds), pustular (pus-filled blisters), and erythrodermic (widespread redness). Psoriasis is associated with psoriatic arthritis in about 30% of patients and increases risk for cardiovascular disease, diabetes, and depression. It follows an unpredictable course with periods of flare-ups and remission. Psoriasis affects approximately 2-3% of the global population, with equal prevalence in men and women. The condition significantly impacts quality of life through physical discomfort, cosmetic concerns, and psychological burden. Plaque psoriasis accounts for 80-90% of cases, presenting as well-demarcated, raised, red plaques covered with silvery scales. Guttate psoriasis often follows streptococcal throat infection, with numerous small lesions appearing suddenly. Inverse psoriasis affects skin folds (armpits, groin, under breasts) with smooth, red patches lacking scales. Pustular psoriasis presents with sterile pustules and can be localized or generalized. Erythrodermic psoriasis is a severe, potentially life-threatening form with widespread inflammation. Nail psoriasis causes pitting, discoloration, and separation from the nail bed. Treatment ranges from topical therapies (corticosteroids, vitamin D analogs, retinoids) for mild disease to phototherapy and systemic medications (methotrexate, cyclosporine, biologics, JAK inhibitors) for moderate-to-severe cases.",
        "root_cause": "The root cause of psoriasis is a complex interplay of genetic susceptibility, immune dysregulation, and environmental triggers. Psoriasis is fundamentally a T-cell mediated autoimmune disease with a strong genetic component. Genome-wide association studies have identified over 60 genetic loci associated with psoriasis susceptibility, with the strongest association in the HLA-C region (PSORS1 locus), particularly HLA-Cw6, which increases risk 10-fold. Other susceptibility genes involve immune regulation (IL-23/Th17 pathway, NF-κB signaling) and skin barrier function. The immunopathogenesis centers on aberrant activation of the IL-23/Th17 axis. Dendritic cells in the skin become activated by triggers (trauma, infection, stress) and produce IL-23 and IL-12. IL-23 stimulates Th17 cells to produce IL-17, IL-22, and TNF-alpha. These cytokines drive keratinocyte hyperproliferation, abnormal differentiation, and inflammation. IL-17 induces keratinocytes to produce antimicrobial peptides, chemokines, and pro-inflammatory mediators, creating a self-amplifying inflammatory loop. Keratinocytes in psoriatic lesions proliferate 10 times faster than normal, with shortened cell cycle (3-5 days versus 28 days). This rapid turnover prevents normal maturation, resulting in parakeratosis (retention of nuclei in the stratum corneum) and the characteristic silvery scales. Environmental triggers include infections (especially streptococcal), medications (lithium, beta-blockers, antimalarials), trauma (Koebner phenomenon), stress, smoking, and alcohol. The Koebner phenomenon—psoriasis developing at sites of skin injury—demonstrates how local factors can trigger disease in genetically susceptible individuals. Obesity and metabolic syndrome are both risk factors and consequences of psoriasis, linked through chronic low-grade inflammation.",
        "causes": "Immune system dysfunction causing T-cells to attack healthy skin cells; genetic predisposition with environmental triggers (stress, infections, injuries, medications)",
        "common_in": "Affects 2-3% of the global population; can begin at any age but peaks at 15-25 and 50-60 years; equal prevalence in men and women"
    },
    "Rosacea": {
        "description": "Rosacea is a chronic inflammatory skin condition primarily affecting the central face—cheeks, nose, chin, and forehead. It typically begins with episodes of flushing and blushing that become more persistent over time. The condition progresses through stages: persistent redness with visible blood vessels (telangiectasia), inflammatory papules and pustules resembling acne, and in severe cases, skin thickening particularly on the nose (rhinophyma). Ocular rosacea affects the eyes, causing dryness, irritation, and redness. Triggers vary among individuals but commonly include sun exposure, hot beverages, spicy foods, alcohol, temperature extremes, stress, and certain skincare products. While there's no cure, treatments can effectively control symptoms and prevent progression. Rosacea affects an estimated 415 million people worldwide, most commonly fair-skinned individuals of Northern European descent. The condition typically begins after age 30 and is more frequently diagnosed in women, though men often have more severe symptoms, particularly rhinophyma. Four subtypes are recognized: erythematotelangiectatic (persistent redness and visible blood vessels), papulopustular (acne-like breakouts), phymatous (skin thickening), and ocular (eye involvement). Many patients have overlapping features. Flushing episodes can last minutes to hours, triggered by vasodilatory stimuli. Persistent erythema results from chronic inflammation and vascular changes. Papules and pustules are inflammatory but not caused by bacterial infection, distinguishing rosacea from acne. Rhinophyma, most common in men, involves sebaceous gland hyperplasia and fibrosis, creating a bulbous, irregular nose. Treatment includes trigger avoidance, gentle skincare, topical medications (metronidazole, azelaic acid, ivermectin), oral antibiotics (doxycycline), laser therapy for telangiectasia, and surgical correction for rhinophyma.",
        "root_cause": "The root cause of rosacea involves a complex interplay of neurovascular dysregulation, innate immune system abnormalities, and microbiome alterations. The pathophysiology is multifactorial and not completely understood. Neurovascular dysfunction is central—patients with rosacea have increased density of blood vessels in facial skin and heightened sensitivity to vasodilatory stimuli. Transient receptor potential vanilloid (TRPV) channels, particularly TRPV1, are overexpressed in rosacea skin. These channels respond to heat, capsaicin, and other triggers, causing vasodilation and neurogenic inflammation. Cathelicidin, an antimicrobial peptide part of the innate immune system, is abnormally processed in rosacea skin. Elevated levels of kallikrein 5, a serine protease, cleave cathelicidin into pro-inflammatory fragments that promote angiogenesis, inflammation, and attract inflammatory cells. This creates a cycle of inflammation and vascular proliferation. Demodex folliculorum mites, which normally inhabit facial hair follicles, are found in higher densities in rosacea patients. While their exact role is debated, they may trigger inflammation through mechanical irritation, bacterial antigens from their microbiome (Bacillus oleronius), or immune responses to mite proteins. Genetic factors contribute—family history increases risk, and certain genetic variants affecting immune responses and vascular function are associated with rosacea. Environmental factors including UV radiation cause oxidative stress and inflammation. Helicobacter pylori infection has been linked to rosacea in some studies, possibly through systemic inflammatory effects or gastrin-induced vasodilation. The gut-skin axis may play a role, with gastrointestinal conditions like SIBO (small intestinal bacterial overgrowth) more common in rosacea patients.",
        "causes": "Exact cause unknown; involves vascular abnormalities, immune dysfunction, Demodex mites, and possibly Helicobacter pylori; genetic and environmental factors contribute",
        "common_in": "Adults over 30, particularly fair-skinned individuals of Northern European descent; more frequently diagnosed in women, though men often have more severe symptoms"
    },
    "Seborrheic Keratoses": {
        "description": "Seborrheic keratoses are extremely common benign skin growths that appear as waxy, stuck-on looking lesions. They range in color from light tan to brown or black and have a characteristic warty, scaly surface texture. These growths can appear anywhere on the body except palms and soles, most commonly on the face, chest, shoulders, and back. They typically start as small, rough bumps and gradually thicken and develop their distinctive appearance. While completely harmless and not contagious, seborrheic keratoses can be cosmetically bothersome or become irritated by clothing or jewelry. They don't require treatment unless symptomatic or for cosmetic reasons. Despite their appearance, they have no connection to skin cancer. Seborrheic keratoses are among the most common benign skin tumors, with prevalence increasing dramatically with age—nearly universal by age 70. They're sometimes called 'wisdom warts' or 'barnacles of aging.' The lesions have a characteristic 'stuck-on' appearance, as if they could be peeled off. Surface features include a warty or verrucous texture with keratin-filled cysts (horn cysts or pseudo-horn cysts) visible on close inspection. Colors vary from flesh-toned to tan, brown, or black, sometimes with multiple colors in a single lesion. Size ranges from a few millimeters to several centimeters. The sign of Leser-Trélat—sudden appearance of multiple seborrheic keratoses—may rarely indicate internal malignancy, though this association is controversial. Dermatosis papulosa nigra, common in darker-skinned individuals, represents a variant with multiple small, dark lesions on the face. Treatment options include cryotherapy, curettage, electrodesiccation, or laser removal for symptomatic or cosmetically concerning lesions. Biopsy may be performed if melanoma cannot be excluded clinically.",
        "root_cause": "The root cause of seborrheic keratoses involves clonal proliferation of epidermal keratinocytes, but the exact trigger remains unclear. These lesions represent benign neoplasms arising from the epidermis, characterized by proliferation of basaloid or squamoid cells with retention of keratin, creating the characteristic stuck-on appearance. Recent genetic studies have identified specific mutations in seborrheic keratoses, providing insights into their development. The most common mutation involves the FGFR3 (fibroblast growth factor receptor 3) gene, found in approximately 40-60% of lesions. FGFR3 mutations cause constitutive activation of the receptor, promoting cell proliferation through the RAS-MAPK and PI3K-AKT signaling pathways. Interestingly, similar FGFR3 mutations occur in bladder cancer and certain skeletal dysplasias, suggesting this pathway is crucial for keratinocyte proliferation. PIK3CA mutations, affecting the PI3K-AKT pathway, are found in about 30% of seborrheic keratoses. These mutations promote cell survival and proliferation. Some lesions harbor RAS mutations (HRAS, KRAS). The presence of these oncogenic mutations raises the question of why seborrheic keratoses remain benign. The answer likely involves oncogene-induced senescence—the mutations trigger initial proliferation but also activate growth-arrest mechanisms preventing malignant transformation. Age-related factors clearly play a role, as prevalence increases dramatically with aging. Cumulative UV exposure may contribute, though seborrheic keratoses also occur on non-sun-exposed areas. Genetic predisposition is evident—they tend to run in families, suggesting inherited susceptibility. Hormonal factors may influence development, as lesions sometimes appear or enlarge during pregnancy. The sudden appearance of multiple lesions (sign of Leser-Trélat) in association with internal malignancy suggests that tumor-derived growth factors might stimulate seborrheic keratosis development, though this remains controversial.",
        "causes": "Exact cause unknown; appear to be related to aging and possibly genetics; sun exposure may play a role but they also occur on non-sun-exposed areas",
        "common_in": "Adults over 50; extremely common in elderly (nearly universal by age 70); tend to run in families"
    },
    "Skin Cancer": {
        "description": "Skin cancer is the abnormal, uncontrolled growth of skin cells, most commonly caused by ultraviolet radiation damage. The three main types are basal cell carcinoma (BCC), squamous cell carcinoma (SCC), and melanoma. BCC, the most common, appears as pearly bumps or flat, flesh-colored lesions, rarely spreading but causing local tissue destruction. SCC presents as firm, red nodules or flat, scaly patches and can metastasize if untreated. Melanoma, the most dangerous form, develops from melanocytes and can spread rapidly to other organs. Warning signs include new growths, sores that don't heal, or changes in existing moles. Early detection dramatically improves outcomes—the 5-year survival rate for early-stage melanoma exceeds 99%. Regular skin checks are essential. Skin cancer is the most common cancer globally, with over 5 million cases diagnosed annually in the United States alone. BCC accounts for approximately 80% of non-melanoma skin cancers, typically appearing on sun-exposed areas like the face and neck. It grows slowly and rarely metastasizes but can cause significant local destruction if untreated. SCC comprises about 20% of non-melanoma skin cancers, with higher metastatic potential, especially in high-risk locations (ears, lips) or immunosuppressed patients. Melanoma, though less common, causes the majority of skin cancer deaths. Subtypes include superficial spreading (most common), nodular (aggressive), lentigo maligna (sun-damaged skin), and acral lentiginous (palms, soles, nails, more common in darker-skinned individuals). Risk factors include fair skin, history of sunburns, many moles, family history, immunosuppression, and exposure to carcinogens. Prevention through sun protection (sunscreen, protective clothing, avoiding peak sun hours) is crucial. Treatment options include surgical excision, Mohs micrographic surgery, cryotherapy, topical medications, radiation therapy, and for advanced melanoma, immunotherapy and targeted therapy.",
        "root_cause": "The root cause of most skin cancers is cumulative DNA damage to skin cells caused by ultraviolet (UV) radiation from sunlight or artificial sources like tanning beds. UV radiation, particularly UVB (280-320 nm), directly damages DNA by creating pyrimidine dimers and other photoproducts that distort the DNA double helix. UVA (320-400 nm) contributes through generation of reactive oxygen species causing oxidative DNA damage. When DNA repair mechanisms cannot correct this damage, mutations accumulate in critical genes regulating cell growth, differentiation, and apoptosis. In BCC, the key pathway involves mutations in the hedgehog signaling pathway, particularly the PTCH1 tumor suppressor gene. Loss of PTCH1 function leads to constitutive activation of the hedgehog pathway, driving uncontrolled proliferation of basal cells. Most BCCs harbor PTCH1 mutations, and germline PTCH1 mutations cause Gorlin syndrome (basal cell nevus syndrome) with multiple BCCs. SCC development involves progressive accumulation of mutations, often beginning with actinic keratosis. Key mutations affect the p53 tumor suppressor gene (found in over 90% of SCCs), causing loss of cell cycle control and apoptosis resistance. Additional mutations in RAS oncogenes, NOTCH genes, and other pathways contribute to malignant transformation. Melanoma pathogenesis involves mutations in genes controlling melanocyte proliferation and survival. BRAF mutations (particularly V600E) occur in about 50% of melanomas, activating the MAPK pathway. NRAS mutations are found in 15-20%. Loss of CDKN2A (encoding p16) removes cell cycle checkpoints. Mutations in TERT promoter enable unlimited replicative potential. Genetic susceptibility plays a role—fair skin with less protective melanin, variants in MC1R gene (red hair, freckling), and familial melanoma syndromes (CDKN2A, CDK4 mutations) increase risk. Immunosuppression impairs immune surveillance of abnormal cells, dramatically increasing skin cancer risk in organ transplant recipients.",
        "causes": "Primarily UV radiation from sun or tanning beds causing DNA damage; risk factors include fair skin, history of sunburns, many moles, family history, and immunosuppression",
        "common_in": "Risk increases with age; fair-skinned individuals at highest risk; melanoma increasingly common in young adults, especially women (tanning bed use)"
    },
    "Sun/Sunlight Damage": {
        "description": "Sun damage, or photoaging, encompasses the cumulative effects of ultraviolet radiation on the skin over time. Unlike chronological aging, photoaging is characterized by specific changes: deep wrinkles, rough and leathery texture, mottled pigmentation (age spots, freckles), loss of skin elasticity, visible blood vessels (telangiectasia), and a sallow, yellowish complexion. The damage occurs in the dermis where UV rays break down collagen and elastin fibers, the structural proteins that keep skin firm and supple. Sun damage also increases the risk of precancerous conditions (actinic keratosis) and skin cancers. The effects are cumulative and largely irreversible, though treatments can improve appearance. Prevention through sun protection is far more effective than treatment. Photoaging manifests differently than intrinsic aging. While chronologically aged skin is thin, fine-wrinkled, and pale, photoaged skin is thick, coarse, deeply wrinkled, and irregularly pigmented. Solar elastosis—accumulation of abnormal elastic tissue in the dermis—gives skin a yellowish, leathery appearance. Lentigines (age spots or liver spots) are flat, brown patches resulting from localized melanocyte proliferation. Telangiectasias are permanently dilated blood vessels visible as red lines. Poikiloderma of Civatte causes reddish-brown discoloration on the sides of the neck. Actinic purpura (senile purpura) presents as purple bruises on forearms from fragile blood vessels. The severity correlates with cumulative UV exposure and skin type—fair-skinned individuals show more dramatic changes. Occupational sun exposure (farmers, construction workers, sailors) and recreational activities (golf, tennis, beach activities) contribute significantly. Treatment options include topical retinoids, chemical peels, laser resurfacing, intense pulsed light therapy, and injectable fillers for wrinkles. Prevention requires consistent sun protection: broad-spectrum sunscreen (SPF 30+), protective clothing, wide-brimmed hats, and avoiding peak sun hours (10 AM-4 PM).",
        "root_cause": "The root cause of sun damage is chronic exposure to ultraviolet radiation, which induces multiple pathological changes at the molecular and cellular levels. UV radiation penetrates the skin and causes both direct and indirect DNA damage. UVB rays directly damage DNA by creating cyclobutane pyrimidine dimers and 6-4 photoproducts, distorting the DNA structure and causing mutations if not repaired. UVA rays, which penetrate deeper into the dermis, generate reactive oxygen species (ROS) that cause oxidative damage to DNA, proteins, and lipids. This oxidative stress overwhelms antioxidant defenses, leading to cellular damage. In the dermis, UV radiation activates matrix metalloproteinases (MMPs), enzymes that degrade collagen and elastin. Specifically, MMP-1 (collagenase) breaks down type I and III collagen, the main structural proteins providing skin firmness. Elastase degrades elastin fibers responsible for skin elasticity. Simultaneously, UV exposure impairs synthesis of new collagen by damaging fibroblasts and disrupting TGF-beta signaling pathways essential for collagen production. The net result is progressive loss of dermal structural support, causing wrinkles and sagging. Solar elastosis occurs when damaged fibroblasts produce abnormal, non-functional elastic fibers that accumulate in the dermis. Pigmentary changes result from UV-induced melanocyte dysfunction. Chronic UV exposure causes uneven melanocyte distribution and activity, leading to hyperpigmented spots (lentigines) and hypopigmented areas. UV radiation also damages dermal blood vessels, causing telangiectasias and impaired microcirculation. Immunosuppression from UV exposure impairs the skin's ability to detect and eliminate precancerous cells, increasing skin cancer risk. The cumulative nature of photoaging reflects that UV damage accumulates over decades, with each exposure adding to the total burden. Genetic factors influence susceptibility—fair skin with less melanin protection, polymorphisms in DNA repair genes, and antioxidant enzyme variants affect individual photoaging rates.",
        "causes": "Chronic exposure to ultraviolet A (UVA) and ultraviolet B (UVB) radiation from sunlight or artificial sources like tanning beds",
        "common_in": "Anyone with significant sun exposure; most visible in fair-skinned individuals; outdoor workers, athletes, and those in sunny climates at higher risk"
    },
    "Tinea": {
        "description": "Tinea, commonly called ringworm, is a superficial fungal infection caused by dermatophytes—fungi that feed on keratin in skin, hair, and nails. Despite its name, no worm is involved; the term comes from the ring-shaped rash it often produces. Different body locations have specific names: tinea corporis (body), tinea pedis (athlete's foot), tinea cruris (jock itch), tinea capitis (scalp), and tinea unguium (nails/onychomycosis). The infection typically presents as circular, red, scaly patches with raised borders and clearer centers. It's highly contagious, spreading through direct contact with infected individuals, animals, or contaminated surfaces like gym floors and shared towels. Treatment involves topical or oral antifungal medications depending on severity and location. Dermatophytes belong to three genera: Trichophyton (most common, causing most tinea infections), Microsporum (primarily tinea capitis), and Epidermophyton. Tinea corporis presents as expanding, ring-shaped lesions with central clearing and an active, scaly border. Tinea pedis affects the feet, causing itching, scaling, and fissuring between toes (interdigital type), diffuse scaling on soles (moccasin type), or vesicles and bullae (vesiculobullous type). Tinea cruris affects the groin and inner thighs, more common in men, presenting as red, itchy patches with well-defined borders. Tinea capitis, primarily affecting children, causes scaly patches, hair loss, and sometimes painful, inflamed nodules (kerion). Tinea unguium (onychomycosis) causes nail thickening, discoloration, and crumbling. Diagnosis is confirmed by KOH preparation showing fungal hyphae or fungal culture. Treatment ranges from topical antifungals (clotrimazole, terbinafine) for localized infections to oral antifungals (griseofulvin, terbinafine, itraconazole) for extensive, resistant, or nail/scalp involvement.",
        "root_cause": "The root cause of tinea infections is invasion of keratinized tissues (stratum corneum, hair, nails) by dermatophyte fungi. These fungi have evolved to digest keratin, the structural protein in these tissues, as their primary nutrient source. Dermatophytes produce keratinases, proteolytic enzymes that break down keratin into amino acids the fungi can absorb. The infection begins when fungal spores or hyphal fragments contact the skin surface. For infection to establish, several conditions must be met. First, the fungi must adhere to keratinocytes, mediated by adhesins and mannoproteins on the fungal cell wall. Second, the local environment must favor fungal growth—dermatophytes thrive in warm, moist conditions, explaining why infections are common in occluded areas (feet in shoes, groin, skin folds). Third, the host's immune defenses must be overcome or evaded. The stratum corneum provides a physical barrier, and antimicrobial peptides, complement proteins, and resident immune cells provide defense. However, dermatophytes have evolved mechanisms to evade immunity, including production of proteases that degrade antimicrobial peptides and complement components. Once established, the fungi spread centrifugally (outward from the initial site), creating the characteristic ring-shaped lesion. The active border represents the advancing edge of infection, while the center may clear as the immune response controls fungal growth. The inflammatory response to fungal antigens causes redness, itching, and scaling. Factors promoting infection include compromised skin barrier (trauma, maceration), immunosuppression (diabetes, HIV, corticosteroid use), genetic susceptibility (certain HLA types), and environmental exposure (communal showers, contact sports, pet exposure). Tinea capitis is more common in children due to differences in scalp sebum composition—adult sebum contains fungistatic fatty acids. Recurrent infections often result from reinfection from contaminated fomites, infected family members or pets, or inadequate treatment duration.",
        "causes": "Dermatophyte fungi (Trichophyton, Microsporum, Epidermophyton species) thriving in warm, moist environments; spread through direct contact or contaminated objects",
        "common_in": "Athletes (especially swimmer's and athlete's foot), children (tinea capitis), people using shared facilities, pet owners, and those in humid climates"
    },
    "Unknown/Normal": {
        "description": "This classification indicates that the analyzed skin appears within normal parameters or that the AI system could not confidently identify a specific condition from the image provided. Normal skin varies significantly among individuals based on factors like ethnicity, age, sun exposure history, and genetics. Variations in skin texture, minor pigmentation differences, and small benign features are common and typically not concerning. If you're experiencing symptoms or have concerns about your skin despite this result, we strongly recommend consulting a dermatologist for a professional evaluation. Factors like image quality, lighting, or the angle of the photograph may also affect the AI's ability to make a definitive assessment. Normal skin characteristics include smooth texture, even tone, appropriate moisture balance, and absence of lesions, rashes, or abnormal growths. However, 'normal' encompasses a wide spectrum. Skin type varies from oily to dry, with combination patterns common. Pigmentation ranges from very fair to very dark, with variations within ethnic groups. Freckles, beauty marks, and minor textural variations are normal findings. Age-related changes like fine lines, mild laxity, and subtle pigmentary changes are part of normal aging. Transient findings like mild redness from recent washing, temporary pressure marks, or minor irritation don't indicate pathology. The AI system is trained to identify specific pathological patterns associated with skin diseases. When these patterns are absent or ambiguous, the system returns this classification. This doesn't necessarily mean the skin is perfectly healthy—subtle or early-stage conditions, rare diseases not in the training set, or conditions requiring clinical context (symptoms, history, physical examination) may not be detected. If you have specific concerns—persistent symptoms, changes in existing lesions, family history of skin conditions, or risk factors—professional dermatological evaluation is warranted regardless of this result.",
        "root_cause": "N/A - This result may indicate healthy skin or limitations in image analysis. If this classification is returned but you have visible skin changes or symptoms, several factors could be responsible. The image quality may be insufficient for analysis—poor lighting, blur, extreme angles, or low resolution can prevent accurate assessment. The condition may be in an early stage where characteristic features haven't fully developed. The skin change may be a normal variant or benign finding that doesn't match pathological patterns in the AI's training data. Rare conditions not well-represented in training datasets may not be recognized. Some conditions require clinical context beyond visual appearance—symptoms like itching, pain, or burning; duration and evolution of changes; associated systemic symptoms; medication history; and family history all contribute to diagnosis but aren't available from images alone. Certain conditions have variable presentations that may not match typical patterns. Lighting and photography technique significantly affect image appearance—harsh lighting can create shadows mimicking lesions, while poor color balance can distort true skin tones. If you're experiencing symptoms such as persistent itching, pain, burning, or changes in sensation; lesions that bleed, ooze, or don't heal; rapid growth or change in existing marks; or systemic symptoms like fever, fatigue, or joint pain, these warrant professional evaluation regardless of AI analysis. Remember that AI systems are tools to assist, not replace, medical professionals. They lack the ability to palpate lesions, assess texture, perform dermoscopy, correlate with patient history, or apply clinical judgment. A dermatologist can perform comprehensive evaluation including detailed history, full-body skin examination, dermoscopy, and if needed, biopsy for definitive diagnosis.",
        "causes": "N/A - This result may indicate healthy skin or limitations in image analysis due to quality, lighting, or presentation of the condition",
        "common_in": "N/A - Normal skin variations are universal; if symptoms persist, professional evaluation is recommended"
    },
    "Vascular Tumors": {
        "description": "Vascular tumors are growths arising from blood vessels or lymphatic vessels in the skin. The most common type is infantile hemangioma, a benign tumor appearing in infancy as a bright red, raised lesion (strawberry mark) that typically grows rapidly in the first year before gradually involuting over several years. Other types include congenital hemangiomas (present at birth), pyogenic granulomas (rapidly growing red nodules often following minor trauma), and rare malignant forms like angiosarcoma. Cherry angiomas are small, bright red spots common in adults over 30. While most vascular tumors are benign and require no treatment, some may need intervention due to location (near eyes, airways), size, or complications like bleeding or ulceration. Infantile hemangiomas affect 4-5% of infants, more common in premature babies, low birth weight infants, and females (3:1 ratio). They typically appear within the first few weeks of life, undergo rapid proliferation for 6-12 months, then slowly involute over 3-10 years. Most resolve completely, though some leave residual skin changes. Superficial hemangiomas are bright red (strawberry hemangiomas), deep hemangiomas appear bluish, and mixed types have both components. Complications include ulceration (painful, bleeding, infection risk), visual obstruction if near eyes, airway compromise if in the throat, and high-output cardiac failure with very large lesions. PHACE syndrome associates large facial hemangiomas with posterior fossa malformations, arterial anomalies, cardiac defects, and eye abnormalities. Congenital hemangiomas are fully formed at birth and either rapidly involute (RICH) or don't involute (NICH). Pyogenic granulomas are acquired vascular proliferations, often following trauma, appearing as rapidly growing, friable, red nodules that bleed easily. Cherry angiomas (Campbell de Morgan spots) are common benign vascular proliferations in adults, increasing with age. Treatment options include observation, beta-blockers (propranolol, timolol) for problematic infantile hemangiomas, laser therapy, surgical excision, or sclerotherapy depending on type and indication.",
        "root_cause": "The root cause varies by vascular tumor type. Infantile hemangiomas result from abnormal proliferation of endothelial cells forming blood vessels. The pathogenesis involves dysregulated angiogenesis—the process of new blood vessel formation. Current evidence suggests infantile hemangiomas originate from endothelial progenitor cells, possibly of placental origin. Several factors support this theory: hemangiomas express placental markers (GLUT-1, merosin, FcγRII), are more common after placental abnormalities (placenta previa, preeclampsia), and occur more frequently in premature infants where placental-fetal circulation is disrupted. Hypoxia appears to be a key trigger—premature birth, low birth weight, and multiple gestation (all associated with relative hypoxia) increase hemangioma risk. Hypoxia induces expression of hypoxia-inducible factors (HIFs) that upregulate vascular endothelial growth factor (VEGF) and other pro-angiogenic factors, driving endothelial proliferation. The proliferative phase involves rapid endothelial cell division, forming disorganized vascular channels. The involuting phase involves apoptosis of endothelial cells, replacement with fibro-fatty tissue, and vascular regression. The mechanisms triggering involution are not fully understood but involve decreased VEGF expression and increased expression of anti-angiogenic factors. Genetic factors play a role—familial cases occur, and somatic mutations in GNAQ and GNA11 genes have been identified in some hemangiomas. Pyogenic granulomas develop following minor trauma, pregnancy, or certain medications (retinoids, protease inhibitors). The trauma triggers an exaggerated wound healing response with excessive angiogenesis. Hormonal factors during pregnancy promote vascular proliferation. Cherry angiomas result from age-related proliferation of dilated capillaries and venules in the papillary dermis. The exact cause is unknown, but increasing prevalence with age suggests cumulative factors. Genetic predisposition is evident as they run in families. Angiosarcomas, rare malignant vascular tumors, arise from chronic lymphedema (Stewart-Treves syndrome), radiation exposure, or de novo in elderly individuals, involving malignant transformation of endothelial cells with mutations in genes like MYC, TP53, and PLCG1.",
        "causes": "Abnormal proliferation of blood vessel cells; infantile hemangiomas linked to placental tissue; some types triggered by trauma or hormonal factors",
        "common_in": "Infantile hemangiomas affect 4-5% of infants, more common in premature babies and females; cherry angiomas nearly universal in adults over 30"
    },
    "Vasculitis": {
        "description": "Cutaneous vasculitis refers to inflammation of blood vessels in the skin, which can occur as an isolated condition or as part of systemic vasculitis affecting multiple organs. When blood vessel walls become inflamed, they may narrow, weaken, or develop clots, leading to reduced blood flow and tissue damage. Skin manifestations include palpable purpura (raised purple spots that don't blanch with pressure), petechiae (tiny red dots), livedo reticularis (lacy, net-like pattern), ulcers, nodules, and in severe cases, tissue necrosis. The condition can be triggered by infections, medications, autoimmune diseases, or malignancies, though often no cause is identified. Diagnosis requires skin biopsy, and treatment depends on the underlying cause and severity. Vasculitis is classified by vessel size affected. Small vessel vasculitis includes leukocytoclastic vasculitis (most common cutaneous form), IgA vasculitis (Henoch-Schönlein purpura), and urticarial vasculitis. Medium vessel vasculitis includes polyarteritis nodosa and cutaneous polyarteritis nodosa. Large vessel vasculitis (giant cell arteritis, Takayasu arteritis) rarely has prominent skin findings. Leukocytoclastic vasculitis presents with palpable purpura on lower legs, often triggered by medications, infections, or connective tissue diseases. IgA vasculitis, most common in children, causes purpura on buttocks and legs, often with joint pain, abdominal pain, and kidney involvement. Urticarial vasculitis presents with hives that last more than 24 hours and may leave bruising. Polyarteritis nodosa causes painful nodules, livedo reticularis, and ulcers. Diagnosis involves skin biopsy showing vessel wall inflammation with immune complex deposition, neutrophil infiltration, and fibrinoid necrosis. Laboratory tests assess for systemic involvement, underlying causes, and autoantibodies. Treatment ranges from supportive care and removing triggers for mild cases to corticosteroids, immunosuppressants, or biologics for severe or systemic disease.",
        "root_cause": "The root cause of cutaneous vasculitis involves immune-mediated inflammation of blood vessel walls, though the specific mechanisms vary by vasculitis type. The most common mechanism is immune complex-mediated (Type III hypersensitivity) vasculitis. Circulating immune complexes—formed when antibodies bind to antigens (from infections, medications, or self-antigens in autoimmune diseases)—deposit in vessel walls. These immune complexes activate complement, generating C3a and C5a, which are chemotactic for neutrophils. Neutrophils infiltrate vessel walls, release proteolytic enzymes and reactive oxygen species, causing endothelial damage, vessel wall necrosis, and fibrin deposition (fibrinoid necrosis). This process is characteristic of leukocytoclastic vasculitis. In IgA vasculitis, IgA-containing immune complexes deposit in small vessel walls, activating complement via the alternative pathway and causing inflammation. The trigger is often a preceding upper respiratory infection, suggesting molecular mimicry where antibodies against infectious agents cross-react with vascular antigens. ANCA-associated vasculitis involves anti-neutrophil cytoplasmic antibodies (ANCA) that activate neutrophils, causing them to adhere to and damage vessel walls. Cryoglobulinemic vasculitis occurs when cryoglobulins (immunoglobulins that precipitate in cold) form immune complexes that deposit in vessels, often associated with hepatitis C infection. Direct antibody-mediated vasculitis occurs when antibodies directly target vessel wall components. Cell-mediated vasculitis involves T-lymphocytes attacking vessel walls, seen in some drug-induced cases. Triggers include infections (streptococcal, hepatitis B/C, HIV), medications (antibiotics, NSAIDs, diuretics), autoimmune diseases (lupus, rheumatoid arthritis, Sjögren's syndrome), malignancies (lymphoma, leukemia), and inflammatory bowel disease. In many cases, no trigger is identified (idiopathic). Genetic factors influence susceptibility—certain HLA types are associated with specific vasculitis types. The severity and distribution of vascular inflammation determine clinical manifestations, ranging from limited cutaneous involvement to life-threatening systemic disease.",
        "causes": "Immune complex deposition in vessel walls; triggers include infections (hepatitis B/C, strep), medications, autoimmune diseases (lupus, rheumatoid arthritis), and malignancies",
        "common_in": "Can affect any age; specific types have different demographics; leukocytoclastic vasculitis most common in adults; Henoch-Schönlein purpura common in children"
    },
    "Vitiligo": {
        "description": "Vitiligo is a chronic autoimmune condition where the immune system destroys melanocytes, the cells responsible for producing skin pigment (melanin). This results in well-defined, milky-white patches of depigmented skin that can appear anywhere on the body. Common sites include the face (especially around eyes and mouth), hands, feet, arms, and genital areas. The condition may be localized (segmental vitiligo) or widespread (non-segmental vitiligo). Vitiligo affects people of all skin types but is more noticeable in darker-skinned individuals. While not physically harmful or contagious, vitiligo can significantly impact psychological well-being and quality of life. It's associated with other autoimmune conditions like thyroid disease. Treatment options include topical medications, light therapy, and in some cases, surgical procedures. Vitiligo affects 0.5-2% of the world population, with equal prevalence across ethnicities and genders, though it's more visible in darker skin. About 50% of cases begin before age 20, with peak onset in the second and third decades. Non-segmental vitiligo, the most common form (90% of cases), typically presents symmetrically and can be generalized (widespread), acrofacial (hands, feet, face), or universal (affecting most body surface). Segmental vitiligo (10% of cases) follows a dermatomal pattern, usually unilateral, with earlier onset and more stable course. Vitiligo often begins with small patches that gradually enlarge and coalesce. The Koebner phenomenon—new lesions at sites of trauma—is common. Hair in affected areas may also depigment (poliosis). Vitiligo is associated with autoimmune thyroid disease (20-30% of patients), alopecia areata, pernicious anemia, Addison's disease, and type 1 diabetes. Psychological impact can be profound, particularly in cultures where appearance is highly valued. Treatment aims to halt progression and restore pigmentation. Options include topical corticosteroids, calcineurin inhibitors, vitamin D analogs, narrowband UVB phototherapy, excimer laser, JAK inhibitors, and for stable, localized vitiligo, surgical techniques like melanocyte transplantation. Depigmentation therapy may be considered for extensive vitiligo.",
        "root_cause": "The root cause of vitiligo is autoimmune destruction of melanocytes, though the exact trigger and mechanisms are complex and multifactorial. The pathogenesis involves genetic susceptibility, autoimmune responses, oxidative stress, and possibly neural factors. Genetic factors are significant—first-degree relatives have 7-10 times higher risk, and genome-wide association studies have identified over 50 susceptibility loci. Many of these genes regulate immune function (HLA genes, PTPN22, CTLA4, IL2RA) or melanocyte biology (TYR, TYRP1, MC1R). The autoimmune hypothesis is strongly supported by evidence. Patients with vitiligo have circulating autoantibodies against melanocyte antigens, particularly tyrosinase, TYRP-1, and TYRP-2 (enzymes in melanin synthesis). Cytotoxic CD8+ T-lymphocytes infiltrate vitiligo lesions and directly kill melanocytes. These T-cells recognize melanocyte-specific antigens presented by MHC class I molecules. The immune attack is mediated by perforin, granzyme B, and Fas-FasL interactions inducing melanocyte apoptosis. Type I interferons and CXCL10 chemokine play crucial roles in recruiting and activating T-cells. The oxidative stress hypothesis proposes that melanocytes in vitiligo patients are more susceptible to oxidative damage. Melanin synthesis generates reactive oxygen species (ROS) as byproducts. In vitiligo, melanocytes may have defective antioxidant defenses (reduced catalase activity), leading to accumulation of toxic compounds like hydrogen peroxide. Oxidative stress damages melanocytes and releases antigens that trigger autoimmune responses. The neural hypothesis suggests that neurochemical mediators released from nerve endings may be toxic to melanocytes, particularly relevant in segmental vitiligo following dermatomal patterns. Environmental triggers include physical trauma (Koebner phenomenon), emotional stress, sunburn, and exposure to certain chemicals (phenolic compounds). These triggers may initiate melanocyte damage in genetically susceptible individuals, releasing antigens that activate the immune system. The convergence theory integrates these mechanisms: genetic susceptibility creates vulnerable melanocytes, environmental stressors cause oxidative damage and melanocyte stress, damaged melanocytes release antigens and danger signals, and the immune system mounts an autoimmune response that perpetuates melanocyte destruction.",
        "causes": "Autoimmune destruction of melanocytes; genetic predisposition combined with environmental triggers (stress, sunburn, chemical exposure); associated with other autoimmune disorders",
        "common_in": "Affects 0.5-2% of the world population; can begin at any age but 50% develop it before age 20; equal prevalence across ethnicities and genders"
    },
    "Warts": {
        "description": "Warts are benign skin growths caused by human papillomavirus (HPV) infection of the top skin layer. Over 100 HPV types exist, with different types causing warts in different locations. Common warts appear as rough, raised bumps typically on hands and fingers. Plantar warts develop on the soles of feet, growing inward due to pressure and often causing pain when walking. Flat warts are small, smooth, and numerous, commonly on the face and legs. Genital warts are sexually transmitted and require specific medical attention. The virus enters through tiny breaks in the skin and can spread through direct contact or contaminated surfaces. While warts often resolve spontaneously within months to years, treatment can speed resolution and prevent spread. Common warts (verruca vulgaris) are caused primarily by HPV types 2 and 4, appearing as firm, raised papules with a rough, hyperkeratotic surface. Black dots (thrombosed capillaries) are often visible. They commonly occur on hands, fingers, and around nails, where minor trauma facilitates viral entry. Plantar warts (verruca plantaris), caused by HPV types 1, 2, and 4, grow inward due to pressure from walking, causing pain. They're distinguished from calluses by interruption of skin lines and pinpoint black dots. Mosaic warts are clusters of plantar warts. Flat warts (verruca plana), caused by HPV types 3, 10, and 28, are small (1-5mm), smooth, flat-topped papules, often numerous, commonly on the face, hands, and shins. They spread easily through shaving or scratching. Filiform warts are finger-like projections on the face, especially around eyes, nose, and mouth. Periungual warts occur around nails, potentially causing nail deformity. Genital warts (condyloma acuminata), caused by HPV types 6 and 11, are sexually transmitted and appear as flesh-colored or pink, soft papules in the anogenital region. Treatment options include salicylic acid, cryotherapy, cantharidin, immunotherapy (imiquimod, intralesional candida antigen), laser therapy, or surgical removal. Many warts resolve spontaneously as cell-mediated immunity develops, with 65% resolving within 2 years.",
        "root_cause": "The root cause of warts is infection by human papillomavirus (HPV), a double-stranded DNA virus that infects keratinocytes in the epidermis. HPV is highly species-specific and tissue-tropic, with different types showing preference for specific anatomical sites. The virus enters through microtrauma—tiny breaks, cuts, or abrasions in the skin or mucous membranes. Once inside, HPV infects basal keratinocytes, the proliferative cells in the deepest layer of the epidermis. The viral life cycle is intimately linked to keratinocyte differentiation. In basal cells, the virus maintains low-level replication, with viral DNA existing as episomes (circular DNA separate from chromosomes). As infected keratinocytes migrate upward and differentiate, viral gene expression increases. Early viral proteins (E1, E2, E4, E5, E6, E7) manipulate cell cycle regulation, promoting cell proliferation and preventing apoptosis. E6 and E7 proteins are particularly important—they inactivate tumor suppressor proteins p53 and pRb respectively, allowing continued cell division. This drives the hyperproliferation characteristic of warts. In the upper epidermis, late viral proteins (L1, L2) are expressed, forming viral capsids. Viral DNA replication reaches maximum levels, and complete virions are assembled. The thickened, hyperkeratotic surface of warts contains high concentrations of infectious viral particles that can spread to other sites or individuals. The immune response to HPV is primarily cell-mediated. Natural killer cells and cytotoxic T-lymphocytes recognize and kill infected keratinocytes. However, HPV has evolved mechanisms to evade immunity: it doesn't cause cell lysis (remaining hidden inside cells), downregulates MHC class I expression (reducing T-cell recognition), and produces proteins that interfere with interferon signaling. This immune evasion explains why warts can persist for years. Eventually, most individuals develop effective cell-mediated immunity, leading to spontaneous wart resolution. Factors affecting susceptibility include age (children and young adults more susceptible due to lack of prior HPV exposure), immunosuppression (transplant recipients, HIV patients have extensive, treatment-resistant warts), genetic factors (some individuals are more susceptible), and environmental exposure (communal showers, swimming pools, contact sports).",
        "causes": "Human papillomavirus (HPV) infection; virus enters through small cuts or abrasions; spread by direct contact, self-inoculation (touching wart then another body part), or contaminated surfaces",
        "common_in": "Children and young adults (common warts); sexually active adults (genital warts); immunocompromised individuals at higher risk for persistent or widespread warts"
    }
}


def get_disease_description(disease_name: str) -> dict:
    """
    Get the description for a specific disease.
    
    Args:
        disease_name: Name of the disease
    
    Returns:
        Dictionary with description, causes, and common_in fields
    """
    # Try exact match first
    if disease_name in DISEASE_DESCRIPTIONS:
        return DISEASE_DESCRIPTIONS[disease_name]
    
    # Try case-insensitive match
    for key, value in DISEASE_DESCRIPTIONS.items():
        if key.lower() == disease_name.lower():
            return value
    
    # Return default if not found
    return {
        "description": f"Information about {disease_name} is being updated. Please consult a healthcare professional for detailed information about this condition.",
        "causes": "Please consult a healthcare professional",
        "common_in": "Please consult a healthcare professional"
    }


def get_all_disease_descriptions() -> dict:
    """
    Get all disease descriptions.
    
    Returns:
        Dictionary of all disease descriptions
    """
    return DISEASE_DESCRIPTIONS
